STAT September 30, 2024
Allison DeAngelis

The firm is among a select number of biotech VCs to raise new pools of capital this year

DCVC Bio, a Silicon Valley area investment firm launched six years ago by a group of tech, bio,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Investments, Pharma / Biotech, Technology, Trends
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article